Mental Health Clinics in Herlong, CA Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Herlong One Stop Center Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: D.s. Hall Street, Bldg 170, Herlong, CA 96130 Phone: 530-251-8108 |
News Archive
ESC updates Clinical Practice Guidelines on devices for heart failure treatment
The European Society of Cardiology (ESC) today announces a focused update of its Clinical Practice Guidelines covering Device Therapy in Heart Failure. This is the first time that current ESC guidelines have been updated, reflecting the pace of research in this field and the importance of recently published evidence.
Salt Lake City research center joins international drug trial program for painful menstrual cramps
A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating and psychologically taxing and is one of the leading causes of absenteeism from work and school.
Cerus Corporation to raise approximately $12.2 million by selling stocks and warrants
Cerus Corporation (NASDAQ:CERS) today announced that it has entered into definitive agreements with selected investors to sell 6,000,000 units, with each unit consisting of (i) one share of the Company's common stock and (ii) a warrant to purchase 0.4 of a share of the Company's common stock for gross proceeds of approximately $13.2 million in a "registered direct" offering.
Hannover and Rostock team up to develop non-invasive optical melanoma diagnostics
Leibniz University Hannover and Rostock University Medical Center receive funding for the development of non-invasive optical melanoma diagnostics.
Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").
› Verified 4 days ago